Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1994-12-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.91.26.12559PMID 7809077PMCID PMC45478
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characteristics of HIV‐1 gp120 glycoprotein binding to glycolipids

  1994cited by this paper
• Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor.

  1993cited by this paper
• The Galactosyl Ceramide/Sulfatide Receptor Binding Region of HIV-1 gp120 Maps to Amino Acids 206-275

  1993cited by this paper
• Productive infection of a cervical epithelial cell line with human immunodeficiency virus: implications for sexual transmission

  1993cited by this paper
• Improbability of effective vaccination against human immunodeficiency virus because of its intracellular transmission and rectal portal of entry.

  1992cited by this paper
• Human colon epithelial cells productively infected with human immunodeficiency virus show impaired differentiation and altered secretion

  1992cited by this paper
• A quantitative reverse transcriptase-polymerase chain reaction for HIV-1-specific RNA species.

  1992cited by this paper
• Mechanism of HIV spread from lymphocytes to epithelia.

  1992cited by this paper
• Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells

  1992cited by this paper
• Unintegrated human immunodeficiency virus type 1 DNA in chronically infected cell lines is not correlated with surface CD4 expression

  1991cited by this paper
• Women, HIV, and mucosal immunity.

  1991cited by this paper
• Immunizations of monkeys with synthetic peptides disclose conserved areas on gp120 of human immunodeficiency virus type 1 associated with cross-neutralizing antibodies and T-cell recognition.

  1991cited by this paper
• Human immunodeficiency virus can infect the apical and basolateral surfaces of human colonic epithelial cells.

  1991cited by this paper
• Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120.

  1991cited by this paper
• HIV-1 infection and expression in human colonic cells: infection and expression in CD4+ and CD4- cell lines.

  1991cited by this paper
• Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide.

  1991cited by this paper
• Gangliosides in the human glioma cell line U-118 MG grown in culture or as xenografts in nude rats.

  1990cited by this paper
• Neutralizing cross‐reactive and non‐neutralizing monoclonal antibodies to HIV‐1 gp 120

  1990cited by this paper
• Infection of Human Gastrointestinal Cells by HIV-1

  1990cited by this paper
• Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone.

  1989cited by this paper
• CD4-independent infection of human neural cells by human immunodeficiency virus type 1

  1989cited by this paper
• HIV infection of rectal mucosa.

  1988cited by this paper
• Characterization of the binding epitope of a monoclonal antibody to sulphatide.

  1988cited by this paper
• Human retroviruses and AIDS.

  1988cited by this paper
• Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms.

  1988cited by this paper
• Sexual practices and risk of infection by the human immunodeficiency virus. The San Francisco Men's Health Study.

  1987cited by this paper
• Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus

  1987cited by this paper
• Isolation of HTLV-III/LAV from cervical secretions of women at risk for AIDS.

  1986cited by this paper
• Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the virus.

  1986cited by this paper
• Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

  1984cited by this paper
• HTLV-III in the semen and blood of a healthy homosexual man.

  1984cited by this paper
• Separation of gangliosides on a new type of anion-exchange resin.

  1980cited by this paper
• A procedure for the quantitative isolation of brain gangliosides.

  1980cited by this paper

• VP1 of human and murine noroviruses recognizes glycolipid sulfatide via the P domain.

  2024cites this paper
• Convergent Evolution Dynamics of SARS-CoV-2 and HIV Surface Envelope Glycoproteins Driven by Host Cell Surface Receptors and Lipid Rafts: Lessons for the Future

  2023cites this paper
• Endocrine control of mucosal immunity in the human female reproductive tract: Bridging implantation with pathogen protection

  2021cites this paper
• Viral Pandemics of the Last Four Decades: Pathophysiology, Health Impacts and Perspectives

  2020cites this paper
• Sperm can act as vectors for HIV‐1 transmission into vaginal and cervical epithelial cells

  2019cites this paper
• Human IgM monoclonal antibodies block HIV-transmission to immune cells in cervico-vaginal tissues and across polarized epithelial cells in vitro

  2018cites this paper
• Dendrimeric based microbicides against sexual transmitted infections associated to heparan sulfate

  2016cites this paper
• Innate immunity in HIV-1 infection: epithelial and non-specific host factors of mucosal immunity- a workshop report.

  2016cites this paper
• Pivotal Role of the Genital Epithelial Cells in HIV-1 Transmission.

  2015cites this paper
• Effet du liquide séminal sur l'infection par le VIH-1 dans des modèles cellulaires et tissulaires et recherche des facteurs modulateurs

  2014cites this paper
• Oral and Vaginal Epithelial Cell Lines Bind and Transfer Cell-Free Infectious HIV-1 to Permissive Cells but Are Not Productively Infected

  2014cites this paper
• Influence of Common Mucosal Co‐Factors on HIV Infection in the Female Genital Tract

  2014cites this paper
• Transcytosis of HIV-1 through Vaginal Epithelial Cells Is Dependent on Trafficking to the Endocytic Recycling Pathway

  2014cites this paper
• Innate and adaptive anti-HIV immune responses in the female reproductive tract.

  2013cites this paper
• Rôle différentiel des cellules épithéliales intestinales et pulmonaires dans le recrutement des cellules Th17 vers les sites de réplication du virus de l'immunodéficience humaine de type 1

  2012cites this paper
• Understanding Factors That Modulate HIV Infection at the Female Genital Tract Mucosae for the Rationale Design of Microbicides

  2012cites this paper
• Interactions of human immunodeficiency virus type 1 with mucosal epithelial surfaces and Candida albicans

  2012cites this paper
• The Microbiological Context of HIV Resistance: Vaginal Microbiota and Mucosal Inflammation at the Viral Point of Entry

  2012cites this paper
• Advances in HIV microbicide development.

  2011cites this paper
• A dual-chamber model of the female genital tract to evaluate epithelial toxicity of candidate anti-HIV microbicides.

  2011cites this paper
• REVIEW ARTICLE: HIV Infection in the Female Genital Tract: Discrete Influence of the Local Mucosal Microenvironment

  2010cites this paper
• The microbiological context of HIV resistance

  2010cites this paper
• Development of an in vitro dual-chamber model of the female genital tract as a screening tool for epithelial toxicity.

  2010cites this paper
• Microbicides: an emerging science of HIV‐1 prevention in women—15th Conference on Retroviruses and Opportunistic Infections, Boston, USA, 3–6 February 2008

  2009cites this paper
• HIV pathogenesis: 25 years of progress and persistent challenges

  2009cites this paper
• HIV infection of the genital mucosa in women

  2009cites this paper
• Soluble Globotriaosylceramide as a Potential Systemic and Local Inhibitor of HIV Infection

  2009cites this paper
• Apical Interactions of HIV Type 1 with Polarized HEC-1 Cell Monolayer Modulate R5-HIV Type 1 Spread by Submucosal Macrophages

  2009cites this paper
• Setting the stage: host invasion by HIV

  2008cites this paper
• Animal virus receptors

  2008cites this paper
• Setting the stage: host invasion by HIV

  2008cites this paper
• Progress towards an AIDS mucosal vaccine: an overview.

  2007cites this paper
• IgA Antibodies Carrying the b12 V Regionand Cell Transfer by Human Monoclonal IgG Inhibition of HIV-1 Infectivity and Epithelial

  2007cites this paper
• Inhibition of HIV-1 Infectivity and Epithelial Cell Transfer by Human Monoclonal IgG and IgA Antibodies Carrying the b12 V Region1

  2007cites this paper
• DYNAMICS OF THE HIV-2-SPECIFIC IMMUNOGLOBULIN A (IgA) RESPONSE

  2005cites this paper
• Chapter 7 – Cellular and Molecular Basis for Antigen Transport Across Epithelial Barriers

  2005cites this paper
• Selective sequestration of X4 isolates by human genital epithelial cells: Implication for virus tropism selection process during sexual transmission of HIV

  2005cites this paper
• Mucosal Infection and Immune Responses to Simian Immunodeficiency Virus

  2005cites this paper
• The C108g Epitope in the V2 Domain of gp120 Functions as a Potent Neutralization Target When Introduced into Envelope Proteins Derived from Human Immunodeficiency Virus Type 1 Primary Isolates

  2005cites this paper
• A model system of oral HIV exposure, using human palatine tonsil, reveals extensive binding of HIV infectivity, with limited progression to primary infection.

  2004cites this paper
• Inhibition of HIV-1 infection in vitro by human milk sulfated glycolipids and glycosaminoglycans.

  2004cites this paper
• Synthesis of novel, multivalent glycodendrimers as ligands for HIV-1 gp120.

  2004cites this paper
• Novel Polysulfated Galactose-Derivatized Dendrimers as Binding Antagonists of Human Immunodeficiency Virus Type 1 Infection

  2004cites this paper
• Transmission of HIV-1 by primary human uterine epithelial cells and stromal fibroblasts.

  2004cites this paper
• Human immunodeficiency virus type 1 infection of human uterine epithelial cells: viral shedding and cell contact-mediated infectivity.

  2003cites this paper
• Role of Intestinal M Cells in Microbial Pathogenesis

  2003cites this paper
• Human Immunodeficiency Virus Type 1 Infection and Replication in Normal Human Oral Keratinocytes

  2003cites this paper
• Mucosal immunity and vaccination against HIV

  2002cites this paper
• HIV Mucosal Vaccines

  2002cites this paper
• Productive human immunodeficiency virus-1 infection of epithelial cell lines of salivary gland origin.

  2000cites this paper
• Antibody responses to a mucosally delivered HIV-1 gp120-derived C4/V3 peptide.

  2000cites this paper
• Human Immunodeficiency Virus Env-Independent Infection of Human CD4− Cells

  2000cites this paper
• Human Immunodeficiency Virus Env-Independent Infection of Human CD4 2 Cells

  2000cites this paper
• Secretory anti-human immunodeficiency virus (HIV) antibodies in colostrum and breast milk are not a major determinant of the protection of early postnatal transmission of HIV.

  2000cites this paper
• Deletion of the GPG Motif in the HIV Type 1 V3 Loop Does Not Abrogate Infection in All Cells

  2000cites this paper
• Accessibility of glycolipid and oligosaccharide epitopes on rabbit villus and follicle-associated epithelium.

  2000cites this paper
• Secretor polymorphism and human immunodeficiency virus infection in Senegalese women.

  2000cites this paper
• Compartmentalization of the IgG immune response to HIV-1 in breast milk.

  1999cites this paper
• Human immunodeficiency virus infection in vitro activates naturally integrated human papillomavirus type 18 and induces synthesis of the L 1 capsid protein

  1999cites this paper
• A rational basis for mucosal vaccination against HIV infection

  1999cites this paper
• Human immunodeficiency virus infection in vitro activates naturally integrated human papillomavirus type 18 and induces synthesis of the L1 capsid protein.

  1999cites this paper
• Sexual transmission of HIV: infectiousness and prevention.

  1999cites this paper
• The composition and function of M cell apical membranes: implications for microbial pathogenesis.

  1999cites this paper
• Increased prevalence of retrovirus infections among older women in Africa.

  1999cites this paper
• HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160.

  1998cites this paper
• Heparin‐binding domain of human fibronectin binds HIV‐1 gp120/160 and reduces virus infectivity

  1998cites this paper
• HIV transmission and immune protection at mucosal surfaces.

  1998cites this paper
• Immunized with Oligomeric gp160 Respiratory Tracts of Mice Intranasally HIV-1 Neutralizing Antibodies in the Genital and

  1998cites this paper
• Antibody‐secreting cells specific for simian immunodeficiency virus antigens in lymphoid and mucosal tissues of immunized macaques

  1998cites this paper
• Sulfatide inhibits HIV-1 entry into CD4-/CXCR4+ cells.

  1998cites this paper
• Genital Infection of Female Chimpanzees with Human Immunodeficiency Virus Type 1

  1998cites this paper
• Co‐expression of CXCR4/fusin and galactosylceramide in the human intestinal epithelial cell line HT‐29

  1997cites this paper
• Mucosal Immune Response to an HIV C4/V3 Peptide Following Nasal or Intestinal Immunization of Rabbits

  1997cites this paper
• Factors Facilitating the Sexual Transmission of HIV-1

  1997cites this paper
• Proteosomes, emulsomes, and cholera toxin B improve nasal immunogenicity of human immunodeficiency virus gp160 in mice: induction of serum, intestinal, vaginal, and lung IgA and IgG.

  1997cites this paper
• Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins.

  1997cites this paper
• Mucosal Transmission of Cell-Associated and Cell-Free Feline Immunodeficiency Virus

  1997cites this paper
• Detection of functional galactosylceramide (GalCer) receptors on CD4-negative HIV-1 target cells

  1996cites this paper
• Elevated Cerebrospinal Fluid Sulfatide Concentrations as a Sign of Increased Metabolic Turnover of Myelin in HIV Type I Infection

  1996cites this paper
• Sulfated polysaccharides inhibit lymphocyte-to-epithelial transmission of human immunodeficiency virus-1.

  1996cites this paper
• Infection of SK-N-MC cells, a CD4-negative neuroblastoma cell line, with primary human immunodeficiency virus type 1 isolates

  1996cites this paper
• Mucosal Immunity in HIV Infection

  1996cites this paper
• Membrane Glycolipids and Human Immunodeficiency Virus Infection of Primary Macrophages

  1996cites this paper
• Genital and Rectal Mucosal Immunity against Transmission of SIV/HIV

  1996cites this paper
• Interaction of human immunodeficiency virus type 1 envelope protein with liposomes containing galactosylceramide

  1996cites this paper
• Mucosal receptors and T- and B-cell immunity.

  1996cites this paper
• 27 – Rectal and Genital Immunization with SIV/HIV

  1996cites this paper
• Human immunodeficiency viruses.

  1996cites this paper
• SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids.

  1996cites this paper
• - Scarano immunodeficiency virus type 1 isolates . neuroblastoma cell line , with primary human Infection of SK-NMC cells , a CD 4-negative

  1996cites this paper
• Differential distribution of galactosylceramide, H antigen, and carcinoembryonic antigen in rhesus macaque digestive mucosa.

  1996cites this paper
• Shedding of HIV-1 in the genital tract.

  1996cites this paper
• Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques

  1996cites this paper
• Microbial recognition of target-cell glycoconjugates.

  1995cites this paper
• Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus

  1995cites this paper
• The Retroviridae

  1995cites this paper
• High prevalence of serum IgA HIV-1 infection-enhancing antibodies in HIV-infected persons. Masking by IgG.

  1995cites this paper
• Human immunodeficiency virus type 1 infection of SK-N-MC cells: domains of gp120 involved in entry into a CD4-negative, galactosyl ceramide/3' sulfo-galactosyl ceramide-positive cell line

  1995cites this paper